Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
Journal of Drugs in Dermatology : JDD|May 6, 2025
Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus PanelJoshua Burshtein, Milaan Shah, Danny Zakria, et al.The Journal of Arthroplasty|February 24, 2020
The Effect of Bladder Catheterization Technique on Postoperative Urinary Tract Infections After Primary Total Hip ArthroplastyLuke J Garbarino, Peter A Gold, Hiba Anis, et al.Journal of Drugs in Dermatology : JDD|February 6, 2025
A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis: An Expert Consensus PanelMilaan Shah, Joshua Burshtein, Danny Zakria, et al.Dermatology and Therapy|February 10, 2024
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus PanelJoshua Burshtein, Milaan Shah, Danny Zakria, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 11, 2020
UV biomarker genes for classification and risk stratification of cutaneous actinic keratoses and squamous cell carcinoma subtypesDawn Queen, Yao Shen, Megan H Trager, et al.Journal of Drugs in Dermatology : JDD|September 4, 2024
Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus PanelJoshua Burshtein, Danny Zakria, Milaan Shah, et al.Dermatology Online Journal|October 31, 2025
A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panelMilaan Shah, Lauren Debusk, Angela Rosenberg, et al.Dermatology Online Journal|October 31, 2025
How Janus kinase selectivity impacts efficacy and safety of abrocitinib for atopic dermatitis: an expert consensus panelAngela Rosenberg, Danny Zakria, Lauren DeBusk, et al.Dermatology Online Journal|July 29, 2026
A review of the indications, safety, and efficacy of deucravacitinib: An expert consensus panelMilaan Shah, Lauren DeBusk, M Hunter Bohman, et al.Journal of Drugs in Dermatology : JDD|August 2, 2024
Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus PanelJoshua Burshtein, Milaan Shah, Danny Zakria, et al.Pageof 8